1URW

CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-b]PYRIDAZINE

1URW の概要

• エントリーDOI: 10.2210/pdb1urw/pdb
• 関連するPDBエントリー: 1AQ1 1B38 1B39 1BUH 1CKP 1DI8 1DM2 1E1V 1E1X 1E9H 1F5Q 1FIN 1FQ1 1FVT 1FVV 1G5S 1GIH 1GII 1GIJ 1GY3 1GZ8 1H00 1H01 1H06 1H07 1H08 1H0U 1H0V 1H0W 1H1P 1H1Q 1H1R 1H1S 1H24 1H25 1H26 1H27 1H28 1HCK 1HCL 1JST 1JSU 1JSV 1JVP 1KE5 1KE6 1KE7 1KE8 1KE9 1OGU 1OI9 1OIQ 1OIR 1OIT 1OIU 1OIY 1OKU 1OKV 1OKW 1OL1 1OL2 1P2A 1P5E 1PKD 1QMZ 1URC
• 分子名称: CELL DIVISION PROTEIN KINASE 2, 2-[4-(N-(3-DIMETHYLAMINOPROPYL)SULPHAMOYL)ANILINO]- (3 entities in total)
• 機能のキーワード: serine/threonine-protein kinase, mitosis, transferase
• 由来する生物種: HOMO SAPIENS (HUMAN)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 34455.06

構造登録者

Byth, K.F.,Cooper, N.,Culshaw, J.D.,Heaton, D.W.,Oakes, S.E.,Minshull, C.A.,Norman, R.A.,Pauptit, R.A.,Tucker, J.A.,Breed, J.,Pannifer, A.,Rowsell, S.,Stanway, J.J.,Valentine, A.L.,Thomas, A.P. (登録日: 2003-11-11, 公開日: 2004-04-23, 最終更新日: 2011-07-13)

主引用文献

Byth, K.F.,Cooper, N.,Culshaw, J.D.,Heaton, D.W.,Oakes, S.E.,Minshull, C.A.,Norman, R.A.,Pauptit, R.A.,Tucker, J.A.,Breed, J.,Pannifer, A.,Rowsell, S.,Stanway, J.J.,Valentine, A.L.,Thomas, A.P.
Imidazo[1,2-B]Pyridazines: A Potent and Selective Class of Cyclin-Dependent Kinase Inhibitors
Bioorg.Med.Chem.Lett., 14:2249-, 2004

PubMed Abstract: Modification of imidazo[1,2-a]pyridine CDK inhibitors lead to identification of less lipophilic imidazo[1,2-b]pyridazine series of CDK inhibitors. Although several equivalent compounds from these two series have similar structure and show similar CDK activity, the SAR of the two series differs significantly. Protein inhibitor structure determination has confirmed differences in binding mode and given some understanding of these differences in SAR. Potent and selective imidazo[1,2-b]pyridazine inhibitors of CDK2 have been identified, which show >1 microM plasma levels following a 2mg/kg oral dose to mice.

PubMed: 15081018
DOI: 10.1016/J.BMCL.2004.02.008

実験手法

X-RAY DIFFRACTION (1.6 Å)